Saliva-based diagnostics have emerged as a transformative approach in medical testing, offering a non-invasive and efficient ...

Roche has obtained U.S. government green lights allowing its point-of-care testing system to be used to screen for multiple ...

The FDA granted marketing clearances for infectious disease tests, updates to a digital pathology system, and immunoassays for chronic diseases.

AArly DETECT 2 feasibility study designed to validate earlier results on advanced adenomas over a large population of average ...